Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep

Author： Santamaria J.   Iranzo A.   Tolosa E.  

Publisher： Elsevier

ISSN： 1389-9457

Source： Sleep Medicine, Vol.4, Iss.2, 2003-03, pp. : 153-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Different sleep characteristics in restless legs syndrome and periodic limb movement disorder

By Eisensehr I.   Ehrenberg B.L.   Noachtar S.  

Sleep Medicine, Vol. 4, Iss. 2, 2003-03 ,pp. : 147-152

Elsevier

Access to resources Recommend Favorite

Rotigotine transdermal system for the treatment of restless legs syndrome

By Wu Anny   Wagner Mary L  

Future Neurology, Vol. 4, Iss. 3, 2009-05 ,pp. : 267-277

Future Medicine

Access to resources Recommend Favorite

Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome

By Connor James R.  

Brain, Vol. 132, Iss. 9, 2009-09 ,pp. : 2403-2412

Oxford University Press

Access to resources Recommend Favorite

Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures

By Hening W.A.   Allen R.P.  

Sleep Medicine, Vol. 4, Iss. 2, 2003-03 ,pp. : 95-97

Elsevier

Access to resources Recommend Favorite

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding

By Červenka Simon   Pålhagen Sven E.   Comley Robert A.   Panagiotidis Georgios   Cselényi Zsolt   Matthews Julian C.   Lai Robert Y.   Halldin Christer   Farde Lars  

Brain, Vol. 129, Iss. 8, 2006-08 ,pp. : 2017-2028

Oxford University Press

Access to resources Recommend Favorite